Andrada Mining’s earn-in agreement with SQM is value-accretive partnership. Watch the interview here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 351.80
Bid: 351.90
Ask: 352.20
Change: 0.10 (0.03%)
Spread: 0.30 (0.085%)
Open: 355.40
High: 355.50
Low: 348.90
Prev. Close: 351.70

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

14 Aug 2020 14:00

RNS Number : 2222W
Marks & Spencer Group PLC
14 August 2020
 

Director/PDMR Shareholding

Marks and Spencer Group plc (the 'Company') announces that on 14 August 2020 it was notified of the following transactions in the Company's Ordinary 25p shares undertaken by director / persons discharging managerial responsibility ('PDMRs'):

1. Performance Share Plan

Exercise of awards granted on 14 August 2017 under the Company's Performance Share Plan ('PSP'), of which 11.2% vested as disclosed in the Company's 2019/20 Annual Report and Accounts, and subsequent sale of shares to satisfy the tax and National Insurance liabilities arising as set out below.

PDMR

 

 

Shares exercised on 14 August 2020

Shares sold to cover tax and NI

Shares retained by individual

S Rowe

71,504

33,726

37,778

S Berendji

25,310

11,939

13,371

P Friston

25,310

11,939

13,371

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

1. Performance Share Plan

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

S Rowe

2

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 25p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

1. Exercise of 71,504 shares from the Performance Share Plan.

2. Subsequent sale of 33,726 shares acquired under the PSP award to cover the tax and NI liability, with 37,778 shares retained.

c)

Price(s) and volume(s)

1. Exercise

Price(s)

Volume(s)

Nil cost

71,504

2. Sale

Price(s)

Volume(s)

£1.113

33,726

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

71,504

 £0.00

2. Sale

Price(s)

Volume(s)

Total

£1.113

33,726

 £37,537.04

e)

Date of the transaction

2020-08-14

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

S Berendji

2

Reason for the notification

a)

Position/status

PDMR (Retail, Operations & Property Director)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 25p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

1. Exercise of 25,310 shares from the Performance Share Plan.

2. Subsequent sale of 11,939 shares acquired under the PSP award to cover the tax and NI liability, with 13,371 shares retained.

c)

Price(s) and volume(s)

1. Exercise

Price(s)

Volume(s)

Nil cost

25,310

2. Sale

Price(s)

Volume(s)

£1.113

11,939

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

25,310

 £0.00

2. Sale

Price(s)

Volume(s)

Total

£1.113

11,939

 £13,288.11

e)

Date of the transaction

2020-08-14

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

P Friston

2

Reason for the notification

a)

Position/status

PDMR (International Director)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 25p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

1. Exercise of 25,310 shares from the Performance Share Plan.

2. Subsequent sale of 11,939 shares acquired under the PSP award to cover the tax and NI liability, with 13,371 shares retained.

c)

Price(s) and volume(s)

1. Exercise

Price(s)

Volume(s)

Nil cost

25,310

2. Sale

Price(s)

Volume(s)

£1.113

11,939

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

25,310

 £0.00

2. Sale

Price(s)

Volume(s)

Total

£1.113

11,939

 £13,288.11

e)

Date of the transaction

2020-08-14

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLZLFFBVLEBBL
Date   Source Headline
2nd Sep 20249:00 amRNSTotal Voting Rights
30th Aug 202410:37 amRNSDirector/PDMR Shareholding
29th Aug 20249:00 amRNSDirector/PDMR Shareholding
20th Aug 202411:05 amRNSDirector/PDMR Shareholding
8th Aug 202411:30 amRNSConfirmation of CFO appointment date
1st Aug 20249:00 amRNSTotal Voting Rights
31st Jul 20249:00 amRNSDirector/PDMR Shareholding
8th Jul 20242:37 pmRNSDirector/PDMR Shareholding
3rd Jul 20244:45 pmRNSDirectorate Change
3rd Jul 20244:11 pmRNSDirector/PDMR Shareholding
2nd Jul 20241:30 pmRNSResult of AGM
1st Jul 20249:00 amRNSBlock listing Interim Review
1st Jul 20249:00 amRNSTotal Voting Rights
28th Jun 20245:55 pmRNSDirector/PDMR Shareholding
27th Jun 20244:51 pmRNSHolding(s) in Company
25th Jun 202411:26 amRNSDirector Declaration
3rd Jun 202410:00 amRNSAnnual Financial Report
3rd Jun 20249:00 amRNSTotal Voting Rights
30th May 202412:41 pmRNSDirector/PDMR Shareholding
29th May 20244:01 pmRNSCFO announcement
29th May 20242:07 pmRNSDirector/PDMR Shareholding
28th May 20242:04 pmRNSAndrew Fisher to stand down from the Board
22nd May 20247:00 amRNSFinal Results
1st May 20249:00 amRNSTotal Voting Rights
30th Apr 20241:13 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:00 amRNSTotal Voting Rights
28th Mar 20245:23 pmRNSHolding(s) in Company
28th Mar 20243:07 pmRNSDirector/PDMR Shareholding
26th Mar 20243:07 pmRNSDirector/PDMR Shareholding
7th Mar 20243:16 pmRNSHolding(s) in Company
7th Mar 20248:40 amRNSKatie Bickerstaffe - Planned Leadership Evolution
4th Mar 20243:11 pmRNSDirector/PDMR Shareholding
1st Mar 20249:00 amRNSTotal Voting Rights
28th Feb 20241:43 pmRNSDirector/PDMR Shareholding
16th Feb 20249:00 amRNSDirector Declaration
1st Feb 20249:00 amRNSTotal Voting Rights
30th Jan 20242:53 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
15th Jan 20242:36 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSChristmas 2023/2024 Trading
10th Jan 20243:28 pmRNSChange To Board Committee Membership
5th Jan 20244:23 pmRNSHolding(s) in Company
2nd Jan 20249:00 amRNSBlock listing Interim Review
2nd Jan 20249:00 amRNSTotal Voting Rights
28th Dec 202311:40 amRNSDirector/PDMR Shareholding
20th Dec 202311:36 amRNSHolding(s) in Company
19th Dec 202310:30 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSAdditional Listing
12th Dec 20239:13 amRNSDirector/PDMR Shareholding
1st Dec 20239:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Track Your Investments

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.